Abstract
Objective
To study the clinico -hematological profile and treatment outcome in children suffering from auto immune hemolytic anemia (AIHA).
Methods
Twelve children were diagnosed with auto immune hemolytic anemia over a period of four years. Direct antiglobulin test was positive in all the cases. Other causes of hemolytic anemia like thalassemia syndromes, hereditary spherocytosis, G6PD deficiency were excluded by appropriate tests. The children were followed up for 6 months to 4 years.
Results
The age ranged from 7 mth to 9 yr with a mean age of 4.51 yr. All patients had pallor as the presenting complaint followed by splenomegaly (83.3%), jaundice (66.7%), fever (50%) and bleeding manifestations (16.7%). 9 patients had primary disease and 3 had secondary disease. Tubercular infection was seen in 2 patients with secondary disease. Jaundice was seen equally in both the groups. Oral prednisolone produced remission in 83.3% cases. 4 patients (3 in primary and one in secondary group) had relapse after initial response. All responded to a second course of steroids but had subsequent relapses and developed a chronic course.
Conclusion
Autoimmune hemolytic anemia is an uncommon cause of hemolytic anemia in children. Tubercular infection is an underlying pathology in cases of secondary autoimmune hemolytic anemia. Although oral steroids induce remission in most of the cases, relapses are common.
Similar content being viewed by others
References
Segel GB. Hemolytic anemias resulting from extracellular factors. In Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics, 17th ed. Philadelphia; Saunders, 2004; 1638–1640.
Schreiber AD, Gill FM, Manno CS. Auto immune hemolytic anemia. In Nathan DG, Orkin SH, eds. Nathan and Oski’s Hematology of Infancy and Childhood 5th ed. Vol.1. Philadelphia, W.B. Saunders Company, 1998; 501–506.
Sokol RJ, Hewitt S, Stamps BK. Auto immune hemolysis: an 18 year study of 865 cases referred to a regional transfusion centre. Br Med J 1982; 282: 2023–2027.
Vaqlio S, Arista MC, Perrone MP, Tomei G, Testi AM, Coluzzi S, Girelli G. Auto immune hemolytic anemia in childhood: serologic features in 100 cases. Transfusion 2007; 47: 50–54.
Naithani R, Agrawal N, Mahapatra M, Pati H, Kumar R, Choudhary VP. Autoimmune hemolytic anemia in India: clinico-hematological spectrum of 79 cases. Hematology 2006; 11: 73–76.
Choudhary VP, Passi GR, Pati HP. Clinico hematological spectrum of auto immune hemolytic anemia: An Indian experience. J Assoc of Phys India 1996; 44: 112–114.
Mehrotra TN, Gupta AK. Hemolytic anemia associated with alpha methyl dopa (aldomet) therapy. Indian J Med Sci 1971; 25: 550–551.
Abhyankar SH, Agarwal B, Currimbhoy Z. Auto immune hemolytic anemia. Indian Pediatr 1986; 23: 175–179.
Olieveira MC, Oliveira BM, Murao M, Veira ZM, Gresta LT, Viana MB. Clinical course of autoimmune hemolytic anemia: an observational study. J Pediatr (Rio J) 2006, 82: 58–62.
Adil SN, Burney, Khurshid M. Auto immune hemolytic anemia in visceral leishmaniasis. J Park Med Assoc 1999; 49: 100–101.
Hochman JA. Auto immune hemolytic anemia associated with Crohn’s disease. Inflamm Bowel Dis 2002; 8: 98–100.
Dowes KA, Domen RE, McCarron KF et al. Auto immune hemolytic anemia following DTP vaccination: report of a fatal case and review of literature. Clin Pediatr 2001; 40: 355–358.
Bakshi S, Rao IS, Jain V, Arya LS. Auto immune hemolytic anemia complicating disseminated childhood tuberculosis. Indian J Pediatr 2004; 71: 549–551.
Gupta V, Bhatia BD. Abdominal tuberculosis with auto immune anemia: a case report. Indian J Pediatr 2005; 72: 175–176.
Gottardo NG, Baker DL, Willis FR. Successful induction and maintenance of long-term remission in a child with chronic relapsing auto immune hemolytic anemia using rituximab. Pediatr Hematol Oncol 2003; 20: 557–561.
Ramanathan S, Koutts J, Hertzberg MS. Two cases of refractory warm auto immune hemolytic anemia treated with rituximab. Am J Hematol 2005; 78: 123–126.
Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA. High dose cyclophosphamide for refractory auto immune hemolytic anemia. Blood 2002; 100: 704–706.
Heisel MA, Ortega JA. Factors influencing prognosis in childhood autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol 1983; 5: 147–150.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, V., Shukla, J. & Bhatia, B.D. Autoimmune hemolytic anemia. Indian J Pediatr 75, 451–454 (2008). https://doi.org/10.1007/s12098-008-0071-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12098-008-0071-0